Drug Coated Balloons. Alternate to DES !
Shakir Manzoor Khan
Stake holder engagement | Policy Advocate | A Jogii for Health & Community Well-being |Blogger #DEDOC VOICE | #IDF Blue circle voice
Drug-coated balloons (DCBs) have been used in #coronaryinterventions to treat in-stent #restenosis, #smallvesseldisease, and #complexlesionsubsets. The use of #DCBs in #cardiacinterventions has also been investigated as an alternative to drug-eluting stents (DES).
DCBs work by delivering a drug to the target lesion using a balloon coated with an anti-proliferative drug. The drug is released during balloon inflation, and the drug-coated balloon is then withdrawn from the artery, leaving the drug behind to inhibit restenosis.
In some studies, DCBs have shown promising results in reducing restenosis rates compared to traditional balloon angioplasty or bare-metal stents. However, the long-term efficacy and safety of DCBs in coronary interventions are still being evaluated, and more studies are needed to determine the optimal use and patient selection criteria for this technology.
领英推荐
There are several manufacturers of drug-coated balloons (DCBs) for use in cardiac interventions, including:
It's important to note that regulatory approvals and availability may vary by region and country. Patients should consult with their healthcare providers to determine the most appropriate treatment options for their specific condition.
Paediatric Surgeon
1 年https://youtu.be/EdW-7Xm6Okc
Developing Human Factor in Quality | Health | Safety | Environment | Manufacturing and Business Excellence
1 年DCBs still need more clinical trials and R&D as compared to the stability, tolerance, and reliability of existing DESs.